The post NALORPHINE Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses appeared first on Gpatindia: Pharmacy Jobs, Admissions, Scholarships, Conference,Grants, Exam Alerts.
]]>17-allyl-7,8-didehydro-4,5α-epoxymorphinan-3,6α-diol.
S. NO. | PHYSICAL AND CHEMICAL PROPERTIES | |
1 | Molecular weight | 311.4 g/mol |
2 | Physical appearance | Crystals from diethyl ether |
3 | Melting point | 208.5°C |
4 | Solubility | Slightly soluble in water; sparingly soluble in ether |
5 | Octanol/water partition coefficient | 1.86 |
6 | Presence of ring | Piperidine, cyclohexene, tetrahydrofuran, phenyl |
7 | Number of chiral centers | 5 |
Nalorphine acts on to opioid receptors:
i. On mu-receptors it shows antagonistic effects
ii. On kappa receptors, it shows high-efficacy agonistic effects.
SAR for opiates can be summarized as follows:
i. Heroin is processed with cyanogens bromide to give N-cyano derivative.
ii. The N-cyano derivative is hen hydrolyzed by a solution of hydrochloric acid to transform into N-demethylated morphine which is also called as normorphine.
iii. The secondary amine group of normorphine undergoes alkylation with allylbromide to give the desired nalorphine.[1]
Nalorphine is used for:
Side effects Nalorphine are:
Q.1 What can be the correct IUPAC nomenclature of Nalorphine?
a) 17-allyl-7,8-didehydro-4,5α-epoxymorphinan-3,6ß-diol
b) N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
c) N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
d) 17-allyl-7,8-didehydro-4,5α-epoxymorphinan-3,6α-diol
Q.2 Which amongst the following statements is/are incorrect related to the SAR of opiates?
I. On replacement of the methyl group from tertiary nitrogen by hydrogen atom, activity increases.
II. On replacement of N-CH3 by NCH2CH2Ph, activity decreases by 14 times.
III. When the methyl group of tertiary nitrogen replaced by N-allyl/methallyl/propyl, the compound so formed acts like the Drug antagonist
a) I, II
b) I, II, III
c) III
d) I
Q.3 Nalorphine can be synthesized from alkylation of ___________ by allylbromide?
a) Morphine
b) Normorphine
c) Codeine
d) Pentazocine
Q.4 Side effects of drug Nalorphine is/are?
a) Anxiety
b) Hallucinations
c) Confusions
d) All of the above
Q.5 Match the following drugs with their correct molecular weight.
i. Nalorphine | A. 311.4 gm/mol |
ii. Phenacemide | B. 184.49 gm/mol |
iii. Loxapine | C. 178.19 gm/mol |
iv. Enflurane | D. 327.8 gm/mol |
a) i-A, ii-D, iii-C, iv-B
b) i-B, ii-A, iii-D, iv-C
c) i-A, ii-C, iii-D, iv-B
d) i-D, ii-C, iii-A, iv-B
Q.6 An example of drug from class Mixed-opioid antagonist is?
a) Gabapentin
b) Nalorphine
c) Levallorphan
d) Secobarbital
Q.7 The type of ring system found in the structure of Nalorphine is?
a) Piperidine
b) Furan
c) Cyclohexane
d) All of the above
Participate in Online FREE GPAT TEST: CLICK HERE
Participate in Online FREE Pharmacist TEST: CLICK HERE
Participate in Online FREE Drug Inspector TEST: CLICK HERE
ANSWERS
1-d
2-a
3-b
4-d
5-c
6-b
7-d
The post NALORPHINE Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses appeared first on Gpatindia: Pharmacy Jobs, Admissions, Scholarships, Conference,Grants, Exam Alerts.
]]>The post THIOTEPA Synthesis, SAR, MCQ and Chemical Structure appeared first on Gpatindia: Pharmacy Jobs, Admissions, Scholarships, Conference,Grants, Exam Alerts.
]]>IUPAC nomenclature
1,1′,1′′-Phosphorothioyltriaziridine
Thiotepa falls under the category of ethylenimine alkalyting agents.
S. NO. | PHYSICAL AND CHEMICAL PROPERTIES | |
1 | Molecular weight | 189.22 g/mol |
2 | Appearance | White crystalline solid |
3 | Melting point | 51.5°C |
4 | Solubility | 19 mg per 100 ml at NTP |
5 | Octanol water partition coefficient | 0.53 |
6 | Presence of ring | Aziridine rings |
Q.1 Correct IUPAC name for thiotepa can be?
a) 1,1′,2-Phosphorothioyltriaziridine
b) 1,2,2′-Phosphorothioyltriaziridine
c) 1,1′,1′′-Phosphorothioyltriaziridine
d) 1,2,3-Phosphorothioyltriaziridine
Q.2 Predict the incorrect statement related to Thiotepa
a) It is highly toxic
b) It is seldom used now
c) It needs to be converted into its active intermediate to show its effects
d) It has aziridine rings in it
Q.3 Oral rout availability of Thiotepa can be increased through
a) Binding with amino group
b) Binding with benzimidazole ring
c) Binding with substituted phenyl group
d) Both a) and c)
Q.4 Thiotepa shows its effect through
a) Alkylation of guanine base pair of DNA
b) Altering the cell membrane structure of cancerous cells
c) Inhibiting the mitochondria to produce energy
d) Rupturing the nuclear membrane
Q.5 Classification of Thiotepa is
a) Nitrogen mustard alkalyting agent
b)Triazine alkalyting agent
c) Ethylinimine alkalyting agent
d) Nitrosoureas alkalyting agent
Q.6 An important side effect of Thiotepa is
a) Rhabdomyosarcoma
b) Ovarian cancer
c) Low blood cell count
d) Bladder cell apoptosis
Q.7 Number of aziridine rings present in Thioptepa?
a) 1
b) 2
c) 3
d) 0
1-c
2-c
3-d
4-a
5-c
6-c
7-c
References
[1] Van Maanen MJ, Smeets CJ, Beijnen JH. Chemistry, pharmacology and pharmacokinetics of N, N′, N′′-triethylenethiophosphoramide (ThioTEPA). Cancer treatment reviews. 2000 Aug 1;26(4):257-68. [2] Pires J, Kreutz OC, Suyenaga ES, Perassolo MS. PHARMACOLOGICAL PROFILE AND STRUCTURE-ACTIVITY RELATIONSHIP OF ALKYLATING AGENTS USED IN CANCER TREATMENT. [3] Wilson CO, Beale JM, Block JH. Wilson and Gisvold’s textbook of organic medicinal and pharmaceutical chemistry. Baltimore, MD: Lippincott Williams & Wilkins,; 2011: pp.360-362.The post THIOTEPA Synthesis, SAR, MCQ and Chemical Structure appeared first on Gpatindia: Pharmacy Jobs, Admissions, Scholarships, Conference,Grants, Exam Alerts.
]]>